Form 4: Emergent BioSolutions Executive Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Coleen Glessner, EVP at Emergent BioSolutions, disposed of 585 shares of common stock on April 7, 2024, to cover tax obligations.
Summary
- On April 7, 2024, Coleen Glessner, an Executive Vice President at Emergent BioSolutions Inc., disposed of 585 shares of common stock.
- The transaction was executed to cover tax obligations.
- Following the transaction, Glessner directly owns 164,383 shares of Emergent BioSolutions common stock.
Sentiment
Score: 5
Explanation: The document reflects a neutral event (tax-related stock disposal) with no inherent positive or negative implications for the company's overall performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax-related stock disposal, which is a common practice among corporate executives.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders, as it is a routine tax-related stock disposal by an executive.
Key Dates
| Date | Description |
|---|---|
| 04/07/2024 | Date of stock disposal transaction |
| 04/09/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.